Resources from the same session
1505MO - Improving cancer care through broader access to quality biomarker testing: An IQN Path, ECPC and EFPIA initiative
Presenter: Nicola Normanno
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1506MO - Incorporating genetic and non-genetic risk factors in breast cancer risk prediction for healthy women with non-informative genetic test result
Presenter: Anja Tüchler
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1507MO - Selection of quality indicators (QI) by non-hospital professionals for onco-hematology care pathway
Presenter: Mario di Palma
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1508MO - Rationalizing the use of off-label drugs (OLD) within a special medication (ME) program for cancer patients (pt): The Catalan Institute of Oncology (ICO) prognostic score (ICO MEscore)
Presenter: Lucia Notario Rincon
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1509MO - Adherence to the Food and Drug Administration (FDA) guidance for the co-development of two or more investigational new drugs in phase 1/2 cancer trials
Presenter: Justin Moyers
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
1510MO_PR - European cancer patients’ perspectives on Immunotherapy
Presenter: Paraskevas Kosmidis
Session: Mini oral session - Public policy
Resources:
Abstract
Slides
Webcast
Discussion 1505MO, 1506MO and 1507MO
Presenter: Christoph Benedikt Westphalen
Session: Mini oral session - Public policy
Resources:
Slides
Webcast